R. Hasserjian

D. Stevens, G. Williams, S. Shalet, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Cytopenias: Reactive and Neoplastic

S. Loghavi, R. Hasserjian, 2018 .

Quantitation of Bacteria in Bone Marrow from Patients with Typhoid Fever: Relationship between Counts and Clinical Features

N. M. Duong, J. Wain, J. Farrar, 2001, Journal of Clinical Microbiology.

Human cytotoxic T lymphocytes specific for Wilms’ tumor antigen-1 inhibit engraftment of leukemia-initiating stem cells in non-obese diabetic-severe combined immunodeficient recipients

J. Goldman, F. Cotter, S. Xue, 2003, Transplantation.

tp53 deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish

S. Ekker, F. Tirode, G. Nielsen, 2018, eLife.

Case records of the Massachusetts General Hospital. Case 8-2006. A 71-year-old woman with Crohn's disease and altered mental status.

D. Podolsky, R. Gonzalez, R. Hasserjian, 2006, The New England journal of medicine.

Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms.

A. Iafrate, W. Wong, D. Dias-Santagata, 2019, Human pathology.

Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis

S. Rodig, J. Cortes, R. Stone, 2015, Journal of Translational Medicine.

Reactive versus neoplastic bone marrow: problems and pitfalls.

R. Hasserjian, 2008, Archives of pathology & laboratory medicine.

TP 53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS / AML Tracking no : ADV-2021-006239 R 2

P. Cin, O. Weinberg, J. Gagan, 2022 .

TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML

P. D. Dal Cin, D. Arber, O. Weinberg, 2022, Blood advances.

Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal

E. Estey, H. Döhner, R. Hasserjian, 2021, Blood.

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

G. Castellani, A. Viale, M. Cazzola, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Erythroid nuclear dysplasia is associated with inferior outcomes for patients with myelodysplastic syndrome undergoing allogeneic hematopoietic cell transplantation.

Yi-Bin Chen, Z. DeFilipp, A. Brunner, 2021, Leukemia research.

Morphological, Flow Cytometry, and Cytogenetic Diagnosis of MDS

S. Goel, R. Hasserjian, Shalini Goel, 2020 .

The current approach to the diagnosis of myelodysplastic syndromes☆.

O. Weinberg, R. Hasserjian, 2019, Seminars in hematology.

Myelodysplastic syndrome Diagnostic algorithm for lower-risk myelodysplastic syndromes

G. Mufti, D. Mclornan, U. Germing, 2018 .

Diagnostic algorithm for lower-risk myelodysplastic syndromes

G. Mufti, D. Mclornan, U. Germing, 2018, Leukemia.

Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis

W. Tam, D. Arber, Sa A. Wang, 2017, American journal of clinical pathology.

Myelodysplastic syndromes following therapy with hypomethylating agents (HMAs): development of acute erythroleukemia may not influence assessment of treatment response

L. Jeffrey Medeiros, G. Garcia-Manero, K. Patel, 2016, Leukemia & lymphoma.

Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts

P. Cin, K. Patel, D. Steensma, 2016, Modern Pathology.

Application of the International Prognostic Scoring System-Revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia

F. Stingo, P. Fox, G. Garcia-Manero, 2014, Leukemia.

Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study

A. Bagg, A. Cherry, G. Raca, 2014, Haematologica.

De novo acute myeloid leukemia with 20–29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study

D. Neuberg, V. Klepeis, A. Bagg, 2014, American journal of hematology.

Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia

Yuehua Wu, A. Muzikansky, A. Fathi, 2013, Modern Pathology.

Rethinking Ormond’s Disease

N. Sainani, J. Stone, V. Deshpande, 2013, Medicine.

Rethinking Ormond’s Disease: “Idiopathic” Retroperitoneal Fibrosis in the Era of IgG4-Related Disease

N. Sainani, J. Stone, V. Deshpande, 2013 .

The World Health Organization (WHO) classification recognizes a group of myeloid neoplasms with overlapping features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms

A. Bagg, P. Fox, D. Arber, 2014 .

Case records of the Massachusetts General Hospital. Case 16-2007. A 61-year-old man with a mediastinal mass.

N. Choi, P. Fidias, J. Shepard, 2007, The New England journal of medicine.

Lymphomatoid Granulomatosis: CT and FDG-PET Findings

Jonathan H. Chung, Carol C Wu, E. Palmer, 2011, Korean journal of radiology.

Diffuse Cellular and Fibrosing Interstitial Pneumonitis With Desquamative Interstitial Pneumonitis-like Features Associated With Myeloid Neoplasia

R. Greene, P. Amrein, E. Mark, 2009, The American journal of surgical pathology.

Case records of the Massachusetts General Hospital. Case 9-2011. A 37-year-old man with flushing and hypotension.

M. Castells, R. Hasserjian, D. Dudzinski, 2011, The New England journal of medicine.

Case 9-2011: A 37-Year-Old Man with Flushing and Hypotension

M. Castells, R. Hasserjian, A. Cort, 2011 .

A phase 1 study of the antibody‐drug conjugate brentuximab vedotin with re‐induction chemotherapy in patients with CD30‐expressing relapsed/refractory acute myeloid leukemia

D. Neuberg, T. Graubert, K. Ballen, 2019, Cancer.

Expression of CD30 in patients with acute graft-versus-host disease.

J. Ritz, R. Soiffer, Heidi Chen, 2012, Blood.

Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim.

B. Bain, G. Mufti, D. Kuter, 2009, Blood.

Myeloid/lymphoid neoplasms with FLT3 rearrangement

A. Bagg, David Wu, D. Arber, 2021, Modern Pathology.

Pan-Cancer Landscape Analysis Reveals Recurrent KMT2A-MAML2 Gene Fusion in Aggressive Histologic Subtypes of Thymoma.

Maristela L Onozato, M. Onozato, D. Dias-Santagata, 2020, JCO precision oncology.

Molecular genetic testing in the diagnosis of myeloid neoplasms

V. Nardi, D. Xia, R. Hasserjian, 2019, Diagnostic Histopathology.

Case records of the Massachusetts General Hospital. Case 13-2006. A 50-year-old man with a painful bone mass and lesions in the liver.

D. Sahani, A. Zhu, A. D’Andrea, 2006, The New England journal of medicine.

Molecular Pathology of Myelodysplastic/Myeloproliferative Neoplasms, Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, and FGFR1, and Mastocytosis

R. Hasserjian, 2010 .

Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?

R. Hoffman, J. Prchal, J. Mascarenhas, 2015, Bone Marrow Transplantation.

ST1571 (imatinib mesylate) reduces bone marrow cellularity and normalizes morphologic features irrespective of cytogenetic response.

I. Lampert, J. Goldman, A. Chase, 2002, American journal of clinical pathology.

Ocular adnexal lymphoma: long-term outcome, patterns of failure and prognostic factors in 174 patients

N. Harris, C. Fung, M. Lucarelli, 2020, Journal of Hematopathology.

2008 WHO classification Acute erythroid leukemia: a reassessment using criteria refined in the

H. Kantarjian, L. Medeiros, L. Abruzzo, 2013 .

Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification.

H. Kantarjian, L. Medeiros, L. Abruzzo, 2010, Blood.

Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis.

P. D. Dal Cin, H. Kantarjian, A. Muzikansky, 2007, American journal of clinical pathology.

Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease.

B. Woda, A. Raza, J. Cerny, 2006, American journal of clinical pathology.

Diverse clinicopathologic features in human herpesvirus 8-associated lymphomas lead to diagnostic problems.

N. Harris, A. Sohani, L. Zukerberg, 2014, American journal of clinical pathology.

Diagnostic utility of cerebrospinal fluid flow cytometry in patients with and without prior hematologic malignancy

F. Preffer, Laura Dillon, A. Sohani, 2014, American journal of hematology.

Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms.

A. Niemierko, G. Garcia-Manero, Sa A. Wang, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Emerging patterns in clonal haematopoiesis

Sagi Abelson, J. Capo-Chichi, D. Xia, 2019, Journal of Clinical Pathology.

Premalignant Clonal Hematopoietic Proliferations.

F. Kuo, V. Nardi, R. Hasserjian, 2019, American journal of clinical pathology.

EBV May Be Expressed in the LP Cells of Nodular Lymphocyte–predominant Hodgkin Lymphoma (NLPHL) in Both Children and Adults

G. Slack, N. Harris, E. Jaffe, 2014, The American journal of surgical pathology.

Hodgkin's lymphoma of the thyroid: a clinicopathologic study of five cases and review of the literature

N. Harris, Sa A. Wang, W. Faquin, 2005, Modern Pathology.

Berardinelli-Seip lipodystrophy

D. Rosenthal, R. Hasserjian, Y. Kobashi, 2007, Skeletal Radiology.

Normal-Karyotype Acute Myeloid Leukemia

R. Hasserjian, 2014 .

Clinicopathologic analysis of follicular lymphoma occurring in children.

F. Behm, P. Banks, R. Lorsbach, 2002, Blood.

The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biology.

J. Goldman, W. Chinswangwatanakul, M. Gordon, 1998, Blood.

A Directly Spliced Exon 10–Containing CD44 Variant Promotes the Metastasis and Homotypic Aggregation of Aggressive Non-Hodgkin's Lymphoma

D. Neuberg, M. Shipp, S. Kharbanda, 1998 .

Myelodysplastic syndromes with no somatic mutations detected by next‐generation sequencing display similar features to myelodysplastic syndromes with detectable mutations

Annette S. Kim, E. Morgan, O. Weinberg, 2021, American journal of hematology.

Chronic myelogenous leukemia in the age of imatinib: assessing response, acceleration, and blast phase

R. Hasserjian, 2011 .

α-CTLA-4 mAb-associated Panenteritis: A Histologic and Immunohistochemical Analysis

Rania M. Seliem, M. Mihm, F. Hodi, 2008, The American journal of surgical pathology.

Case records of the Massachusetts General Hospital. Case 7-2014. A 27-year-old man with diarrhea, fatigue, and eosinophilia.

G. Holmvang, A. Fathi, G. W. Dec, 2014, The New England journal of medicine.

Allo-major histocompatibility complex-restricted cytotoxic T lymphocytes engraft in bone marrow transplant recipients without causing graft-versus-host disease.

H. Stauss, Liquan Gao, L. Gao, 1999, Blood.

Acute myeloid leukemia: advances in diagnosis and classification

R. Hasserjian, 2013, International journal of laboratory hematology.

Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas

D. de Jong, G. Ott, K. Elenitoba-Johnson, 2009, Journal of hematopathology.

Response to “The WHO classification of haematolymphoid tumours” (Editorial)

E. Campo, A. Zelenetz, J. Winter, 2022, Leukemia.

In Response to Lymphohematopoietic Clones

B. Ebert, R. Bejar, D. Steensma, 2022, The Hematologist.

Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study

A. Bagg, D. Arber, S. Sadigh, 2018, Modern Pathology.

Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome

A. Bagg, W. Tam, D. Arber, 2017, Haematologica.

Case records of the Massachusetts General Hospital. Case 14-2006. A 25-year-old woman with anemia and iron overload.

E. Attar, R. Hasserjian, 2006, The New England journal of medicine.

Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination?

C. Sabin, K. Yamamura, M. Pepys, 2004, Immunology.

A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance)

C. Bloomfield, K. Owzar, R. Vij, 2013, Investigational New Drugs.

Granulomatous Lymphadenitis

Jacob R. Bledsoe, R. Hasserjian, 2019, Encyclopedia of Pathology.

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells

Rania M. Seliem, N. Harris, L. Zukerberg, 2011, Journal of hematopathology.

Beyond the lymphocyte predominant cell: CD4+CD8+ T-cells in nodular lymphocyte predominant Hodgkin lymphoma

F. Preffer, A. Rahemtullah, Nancy Lee Harris, 2008, Leukemia & lymphoma.

Functional analysis of the TAN-1 gene, a human homolog of Drosophila notch.

J. Sklar, J. Aster, D. Baltimore, 1994, Cold Spring Harbor symposia on quantitative biology.

Updates on eosinophilic disorders

D. Arber, A. Tzankov, Sa A. Wang, 2022, Virchows Archiv.

Diagnosis of Blood and Bone Marrow Disorders

R. Hasserjian, Sa Wang, Sa A. Wang, 2018, Springer International Publishing.

Low Histologic Grade Follicular Lymphoma With High Proliferation Index: Morphologic and Clinical Features

N. Harris, A. Muzikansky, Lan Wang, 2005, The American journal of surgical pathology.

Follicular Dendritic Cell Sarcoma With Indolent T-Lymphoblastic Proliferation Is Associated With Paraneoplastic Autoimmune Multiorgan Syndrome

N. Harris, M. Pittelkow, W. Macon, 2018, The American journal of surgical pathology.

Flow cytometry to distinguish myelodysplastic syndromes from non-neoplastic causes of cytopenia: ready for prime time?

F. Preffer, R. Hasserjian, 2012, Leukemia research.

Myelodysplastic syndromes with deletions of chromosome 11q lack cryptic MLL rearrangement and exhibit characteristic clinicopathologic features.

G. Garcia-Manero, L. Medeiros, L. Abruzzo, 2011, Leukemia research.

Case records of the Massachusetts General Hospital. Case 27-2010. A 73-year-old woman with chronic anemia.

E. Attar, R. Hasserjian, 2010, The New England journal of medicine.

The International Consensus Classification of acute myeloid leukemia

A. Porwit, D. Arber, E. Duncavage, 2022, Virchows Archiv.

Philadelphia chromosome positive B-cell lymphoblastic lymphoma isolated to bone

Amelia E. Huck, A. Fathi, H. Sadrzadeh, 2013, Leukemia & lymphoma.

Nodular Lymphocyte-Predominant Hodgkin Lymphoma With Atypical T Cells: A Morphologic Variant Mimicking Peripheral T-Cell Lymphoma

N. Harris, E. Jaffe, S. Pittaluga, 2011, The American journal of surgical pathology.

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes

Tae Kon Kim, R. Bejar, O. Abdel-Wahab, 2022, Leukemia.

Lymphoma of the Ocular Adnexa: A Study of 353 Cases

N. Harris, C. Fung, F. Preffer, 2007, The American journal of surgical pathology.

A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML.

S. Choe, R. Stone, A. Fathi, 2021, Blood advances.

TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor.

M. Tomasson, B. Druker, D. Gilliland, 1999, Blood.

Erythroleukemia and Its Differential Diagnosis.

R. Hasserjian, 2013, Surgical pathology clinics.

Deletion of chromosome 20q: friend or foe?

P. D. Dal Cin, R. Hasserjian, P. Dal Cin, 2011, Leukemia research.

Identification of del(20q) in a subset of patients diagnosed with idiopathic thrombocytopenic purpura

P. D. Dal Cin, D. Kuter, J. Vergilio, 2009, British journal of haematology.

Myelodysplastic syndrome with isolated deletion of chromosome 20q: an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation

Raavi Gupta, R. Hasserjian, C. Soupir, 2007, British journal of haematology.

Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group study

A. Bagg, D. Arber, L. Peterson, 2020, International journal of laboratory hematology.

A unique PML-RARα rearrangement involving chromosomes 11, 15, and 17 in a patient with acute promyelocytic leukemia.

P. D. Dal Cin, N. Lindeman, K. Ballen, 2013, Experimental Hematology.

Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemia

A. Fathi, A. Brunner, V. Nardi, 2022, Histopathology.

Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel.

B. Ebert, H. Döhner, R. Larson, 2022, Blood.

Acute erythremic myelosis (true erythroleukaemia): a variant of AML FAB-M6

B. Bain, K. Henry, R. Hasserjian, 2001, Journal of clinical pathology.

FLT3 inhibitor-induced neutrophilic dermatosis.

L. Le, M. Levis, A. Fathi, 2013, Blood.

Whole Genome Sequencing Provides Efficient and Comprehensive Genetic Risk Stratification in Acute Myeloid Leukemia and Myelodysplastic Syndrome

R. Hasserjian, 2021, The Hematologist.

IPSS-M Incorporates Next-Generation Sequencing for a New International Prognostic Scoring System

R. Hasserjian, 2022, The Hematologist.

Case records of the Massachusetts General Hospital. Case 1-2012. An 82-year-old man with persistent ulcers on the hands.

M. Hoang, R. Hasserjian, D. Kroshinsky, 2012, The New England journal of medicine.

Survival of the Fittest: Hypomethylating Agent/BCL-2 Inhibitor Combination Versus Intensive Chemotherapy As Frontline Treatment for Acute Myeloid Leukemia

R. Hasserjian, Michael J. Hochman, 2022, The Hematologist.

Extranodal natural killer T-cell lymphoma, nasal type, with minimal osseous involvement: report of a case and literature review.

Srinivas M Susarla, R. Hasserjian, Basel Sharaf, 2010, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Case records of the Massachusetts General Hospital. Case 8-2008. A 33-year-old man with fever, abdominal pain, and pancytopenia after renal transplantation.

D. Sahani, J. Abramson, C. Kotton, 2008, The New England journal of medicine.

Bone marrow findings correlate with clinical outcome in systemic AL amyloidosis patients

A. Muzikansky, P. Hawkins, H. Lachmann, 2007, Histopathology.

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 19-2004. A 12-year-old boy with fatigue and eosinophilia.

R. Hasserjian, Mary S. Huang, 2004, The New England journal of medicine.

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15-2004. A 31-year-old man with bilateral testicular enlargement.

K. Ballen, R. Hasserjian, 2004, The New England journal of medicine.

Immunophenotyping in the differential diagnosis of histologically low grade B cell lymphomas

A. Wotherspoon, R. Hasserjian, 2000 .

Immunomodulator agent-related lymphoproliferative disorders

N. Harris, S. Perkins, M. Lim, 2009, Modern Pathology.

Primary Follicular Lymphoma of the Gastrointestinal Tract

N. Harris, J. Misdraji, G. Lauwers, 2011, The American journal of surgical pathology.

Leukocytosis: Neutrophilia, Basophilia, and Blasts

R. Hasserjian, C. Ok, 2018 .

Composite chronic myeloid leukemia and essential thrombocythemia with BCR‐ABL1 fusion and CALR mutation

P. D. Dal Cin, E. Hsi, D. Xia, 2018, American journal of hematology.

Recurrences in nodal T-cell lymphoma. Changes in histologic appearance and immunophenotype over the course of disease.

D. Dorfman, A. Shahsafaei, D. Weissmann, 2000, American journal of clinical pathology.

Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T‐cell expansion

B. Woda, A. Raza, N. Galili, 2007, British journal of haematology.

Immunophenotypic Changes and Clinical Outcome in B-Cell Lymphomas Treated with Rituximab

Rania M. Seliem, R. Hasserjian, J. Freeman, 2006, Applied immunohistochemistry & molecular morphology : AIMM.

An unusual lymphoma involving the GI tract and bone marrow

V. Nardi, R. Hasserjian, Roberts Ta, 2022, American journal of hematology.

NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities in the revised 2016 WHO classification

D. Neuberg, B. Ebert, T. Blonquist, 2017, American journal of hematology.

Differential ABC transporter expression during hematopoiesis contributes to neutrophil-biased toxicity of Aurora kinase inhibitors

John N. Hutchinson, D. Ingber, Jianwei Che, 2022, Nature Communications.

NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype.

G. Pinkus, P. Cin, A. Bagg, 2022, Leukemia research.

A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria

A. Bagg, D. Arber, T. George, 2018, Modern Pathology.

Case records of the Massachusetts General Hospital. Case 28-2009. A 68-year-old man with fatigue, cough, and peripheral-blood monocytosis.

T. Spitzer, R. Hasserjian, B. Dey, 2009, The New England journal of medicine.

Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

A. LaCasce, D. Neuberg, P. Armand, 2011, Clinical Cancer Research.

Multiparameter immunophenotyping by flow cytometry in multiple myeloma: The diagnostic utility of defining ranges of normal antigenic expression in comparison to histology

F. Preffer, A. Sohani, R. Hasserjian, 2010, Cytometry. Part B, Clinical cytometry.

Pathology of thymic tumors.

A. Marx, P. Ströbel, R. Hasserjian, 2005, Seminars in thoracic and cardiovascular surgery.

Case records of the Massachusetts General Hospital. Case 17-2006--a 34-year-old man with cavitary lung lesions.

M. Gilman, E. Hochberg, R. Hasserjian, 2006, The New England journal of medicine.

The Seeds of Progression From Myelodysplastic Syndrome to Acute Myeloid Leukemia Are Sown Early in the Course of Disease

R. Hasserjian, 2022, The Hematologist.

Revealing the dark secrets of TP53-mutated AML.

R. Hasserjian, 2022, Blood.

TP53-mutated Acute Myeloid Leukemia and Myelodysplastic Syndrome With Excess Blasts: Two Sides of the Same Coin?

Robert Ta, R. Hasserjian, 2022, The Hematologist.

Comparison of therapy‐related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study

A. Bagg, D. Arber, G. Borthakur, 2020, American journal of hematology.

High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen.

A. Wotherspoon, R. Hasserjian, S. Van Noorden, 1999, Human pathology.

Case records of the Massachusetts General Hospital. Case 30-2006. A 41-year-old man with dyspnea, fever, and lymphadenopathy.

V. Muse, D. Scadden, R. Hasserjian, 2006, The New England journal of medicine.

Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network

Jeffrey W. Clark, Lauren L. Ritterhouse, M. Rivera, 2022, The oncologist.

Introduction.

O. Weinberg, R. Hasserjian, F. Kuo, 2019, American journal of clinical pathology.

mTORC1 links pathology in experimental models of Still’s disease and macrophage activation syndrome

L. Henderson, Zhengping Huang, P. Nigrovic, 2022, Nature Communications.

The International Consensus Classification of myelodysplastic syndromes and related entities

M. Rozman, A. Órfão, Sa A. Wang, 2022, Virchows Archiv.

Infectious Diseases of the Bone Marrow and Spleen

L. Zukerberg, R. Hasserjian, 2018 .

Chapter 12 – Infectious Diseases of the Bone Marrow and Spleen

R. Hasserjian, 2010 .

Clinicopathologic and cytogenetic analysis of malignant rhabdoid tumor of the central nervous system

R. Folkerth, D. Schofield, R. M. Scott, 2005, Journal of Neuro-Oncology.

Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis

G. Slack, N. Harris, A. Sohani, 2009, Leukemia & lymphoma.

Carcinoma of the thymus with clear-cell features. Report of eight cases and review of the literature.

D. Klimstra, J. Rosai, R. Hasserjian, 1995, The American journal of surgical pathology.

TP53‐altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity

H. Kantarjian, N. Daver, A. Wei, 2022, Cancer.

International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data.

M. Loh, E. Estey, M. Cazzola, 2022, Blood.

JAK2, CALR, MPL and ASXL1 mutational status correlates with distinct histological features in Philadelphia chromosome-negative myeloproliferative neoplasms

G. Pinkus, W. Wong, R. Hasserjian, 2017, Haematologica.

Advances in myelodysplastic/myeloproliferative neoplasms

D. Arber, C. Bueso-Ramos, R. Hasserjian, 2022, Virchows Archiv.

Secondary‐type mutations do not impact prognosis in acute myelogenous leukemia AML with mutated NPM1

T. Koyama, A. Seegmiller, S. Strickland, 2022, American journal of hematology.

Spindle cell rhabdomyosarcoma (so-called) in adults: report of two cases with emphasis on differential diagnosis.

J. Fletcher, S. Singer, C. Fletcher, 1998, The American journal of surgical pathology.

Optimal processing of bone marrow trephine biopsy: the Hammersmith Protocol

G. Stamp, I. Lampert, K. Naresh, 2006, Journal of Clinical Pathology.

Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres

B. Bain, G. Mufti, A. Bagg, 2007, British journal of haematology.

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.

B. Ebert, R. Bejar, D. Steensma, 2015, Blood.

Clonal Hematopoiesis and Measurable Residual Disease Assessment in Acute Myeloid Leukemia.

B. Ebert, T. Graubert, D. Steensma, 2020, Blood.

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Mario Cazzola, Robert Hasserjian, C. Bloomfield, 2016, Blood.

Detection of Dual IDH 1 and IDH 2 Mutations by Targeted Next-Generation Sequencing in Acute

Mia Y. Platt, A. Iafrate, S. Yip, 2015 .

Clonal X-chromosome inactivation suggests that splenic cord capillary hemangioma is a true neoplasm and not a subtype of splenic hamartoma

H. Al-Ahmadie, M. Czader, D. Knowles, 2011, Modern Pathology.

PRM-151 in Myelofibrosis: Efficacy and Safety in an Open Label Extension Study

Z. Estrov, T. Manshouri, S. Verstovsek, 2018, Blood.

B-Cell Lymphocytosis

R. Hasserjian, 2018 .

Chapter 13 – Lymphomas of the Bone Marrow

R. Hasserjian, 2011 .

Modulated expression of notch1 during thymocyte development.

J. Sklar, J. Aster, F. Davi, 1996, Blood.

Isolation and functional analysis of a cDNA for human Jagged2, a gene encoding a ligand for the Notch1 receptor

F. Kuo, J. Sklar, J. Aster, 1997, Molecular and cellular biology.

The Notch1 Receptor. Human Jagged2, a Gene Encoding a Ligand for Isolation and Functional Analysis of a Cdna For

F. Kuo, J. Sklar, J. Aster, 1997 .

Oncogenic Forms of NOTCH1 Lacking Either the Primary Binding Site for RBP-Jκ or Nuclear Localization Sequences Retain the Ability to Associate with RBP-Jκ and Activate Transcription*

E. Kieff, J. Sklar, J. Aster, 1997, The Journal of Biological Chemistry.

Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles

J. Sklar, J. Aster, D. Baltimore, 1996, The Journal of experimental medicine.

Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.

Ryan D. Morin, S. South, L. Garraway, 2016, Blood.

Bone progenitor dysfunction induces myelodysplasia and secondary leukemia

Charles P. Lin, J. Rommens, B. Ebert, 2010, Nature.

Diagnostic Yield of CT-Guided Percutaneous Transthoracic Needle Biopsy for Diagnosis of Anterior Mediastinal Masses.

V. Muse, Amita Sharma, S. Digumarthy, 2015, AJR. American journal of roentgenology.

Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology.

Sa A Wang, D. Arber, M. Borowitz, 2017, Archives of pathology & laboratory medicine.

Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells

P. D. Dal Cin, D. Steensma, O. Weinberg, 2020, Haematologica.

B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell Lymphoma

Matija Snuderl, Ephraim P. Hochberg, Aliyah R. Sohani, 2010, The American journal of surgical pathology.

Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1–KMT2A–YAP1 and VIM–KMT2A fusions

E. Sokol, J. Lennerz, B. Alexander, 2020, Modern Pathology.

TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes

M. Arcila, A. Dogan, A. Brunner, 2021, Cancers.

On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology

Carlos F. Ng, D. Ingber, Cailin E. Joyce, 2020, Nature Biomedical Engineering.

Chronic Myelogenous Leukemia

R. Hasserjian, 2012 .

The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13.

Valentina R Minciacchi, C. Bloomfield, C. Plass, 2021, Blood.

Series THE UPDATED WHO CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES The 2016 revision to the World Health Organization classi fi cation of myeloid neoplasms and acute leukemia

C. Bloomfield, M. Cazzola, M. L. Beau, 2016 .

Lymph node FNA cytology: Diagnostic performance and clinical implications of proposed diagnostic categories

A. Ly, R. Hasserjian, M. Delelys, 2021, Cancer cytopathology.

Contribution of Clonal Hematopoiesis to Adult-Onset Hemophagocytic Lymphohistiocytosis.

J. Aster, B. Ebert, A. Schram, 2020, Blood.

High NPM1 mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia

Lauren L. Ritterhouse, P. D. Dal Cin, G. Pinkus, 2019, American journal of hematology.

High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML.

T. Graubert, D. DeAngelo, R. Soiffer, 2018, Blood.

Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities

Traci M. Blonquist, D. Neuberg, B. Ebert, 2018, Haematologica.

Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemia

D. Neuberg, D. DeAngelo, R. Stone, 2015, Modern Pathology.

Hairy Cell Leukemia

R. Hasserjian, 2011 .

Separating Innocuous “CHIP” Mutations From Ominous “CHOP” Mutations in Patients With Treated AML in Remission

R. Hasserjian, M. Fitzpatrick, 2021, The Hematologist.

Flow cytometry reveals the nuances of clonal haematopoiesis

R. Hasserjian, 2021, British journal of haematology.

Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms.

W. Wong, A. Bagg, R. Ptashkin, 2019, Blood advances.

JAK2 V617F‐positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group

A. Bagg, D. Babushok, E. Hsi, 2018, British journal of haematology.

Updates on eosinophilic disorders

D. Arber, A. Tzankov, Sa A. Wang, 2022, Virchows Archiv.

Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures

J. Aster, W. Wong, R. Hasserjian, 2019 .

Prior cytopenia predicts worse clinical outcome in acute myeloid leukemia.

Amelia E. Huck, A. Fathi, A. Brunner, 2015, Leukemia research.

Diffuse large B-cell lymphomas and burkitt lymphoma.

L. de Leval, R. Hasserjian, 2009, Hematology/oncology clinics of North America.

Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group

A. Bagg, W. Tam, D. Arber, 2021, Modern Pathology.

Size Matters in Lymphoma Diagnosis Tissue Biopsy

R. Hasserjian, 2023, The Hematologist.

Small volume biopsy diagnostic yield at initial diagnosis versus recurrence/transformation of follicular lymphoma: A retrospective Cyto‐Heme Interinstitutional Collaborative study

V. Sundaram, O. Lin, J. Abramson, 2022, Cancer cytopathology.

The immunophenotypic spectrum of primary mediastinal large B‐cell lymphoma reveals prognostic biomarkers associated with outcome

N. Harris, Jacob R. Bledsoe, A. Sohani, 2016, American journal of hematology.

Clinicopathologic evaluation of cytopenic patients with isolated trisomy 8: a detailed comparison between idiopathic cytopenia of unknown significance and low-grade myelodysplastic syndrome

P. D. Dal Cin, S. Mathew, Elizabeth M Margolskee, 2017, Leukemia & lymphoma.

Bone marrow niches in haematological malignancies

J. Gribben, D. Steensma, I. Ghobrial, 2020, Nature Reviews Cancer.

Infectious mononucleosis mimicking lymphoma: distinguishing morphological and immunophenotypic features

Abner Louissaint, N. Harris, Nancy L Harris, 2012, Modern Pathology.

Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma

M. Selig, E. Severson, S. Sadigh, 2021, The oncologist.

JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology

Annette S. Kim, E. Severson, S. Ramkissoon, 2021, The American journal of surgical pathology.

Introduction2017 Society for Hematopathology/European Association for Haematopathology Workshop Report

O. Weinberg, F. Kuo, R. Hasserjian, 2019 .

Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification

B. Woda, A. Raza, Sa A. Wang, 2008, Modern Pathology.

CT-guided bone marrow aspirations and biopsies: retrospective study and comparison with blind procedures

M. Bredella, A. Yee, F. Simeone, 2020, Skeletal Radiology.

Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment

G. Pinkus, G. Inghirami, S. Rodig, 2020, Modern Pathology.

Detection of the KITD816V mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis

Annette S. Kim, G. Pinkus, J. Aster, 2020, Modern Pathology.

Small‐cell predominant extranodal NK/T cell lymphoma, nasal type: clinicopathological analysis of a series of cases diagnosed in a Western population

N. Harris, F. Climent, G. Krings, 2016, Histopathology.

Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement.

R. Siebert, N. Harris, A. Iafrate, 2012, Blood.

Primary Follicular Lymphoma of the Testis and Epididymis in Adults

A. Rohatiner, M. Du, A. Dogan, 2007, The American journal of surgical pathology.

Author Correction: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology

Carlos F. Ng, D. Ingber, Cailin E. Joyce, 2020, Nature Biomedical Engineering.

European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia

T. Barbui, C. Bueso-Ramos, G. Barosi, 2017, American journal of hematology.

Differential regulation of myeloid leukemias by the bone marrow microenvironment

D. Scadden, R. V. van Etten, D. Dombkowski, 2012, Nature Medicine.

Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome.

M. Meyerson, D. Gevers, F. Duke, 2013, The New England journal of medicine.

Impact of bone marrow pathology on the clinical management of Philadelphia chromosome-negative myeloproliferative neoplasms.

S. Verstovsek, R. Hasserjian, O. Pozdnyakova, 2015, Clinical lymphoma, myeloma & leukemia.

Case records of the Massachusetts General Hospital. Case 33-2007. A 49-year-old HIV-positive man with anemia.

E. Attar, R. Hasserjian, S. Aquino, 2007, The New England journal of medicine.

Primary lymphoma of bone in the pediatric and young adult population.

O. Weinberg, Karen M. Chisholm, R. Hasserjian, 2017, Human pathology.

Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified

P. Cin, A. Bagg, W. Tam, 2016, Modern Pathology.

Case 37-2016. An 86-Year-Old Woman with Leukocytosis and Splenomegaly.

Naveen M. Kulkarni, T. Graubert, A. Fathi, 2016, The New England journal of medicine.

Case records of the Massachusetts General Hospital. Case 35-2008. A 65-year-old man with confusion and memory loss.

K. Daffner, J. Sherman, R. Gonzalez, 2008, The New England journal of medicine.

The importance of central pathology review in international trials: a comparison of local versus central bone marrow reticulin grading

S. Rodig, J. Thiele, R. Hasserjian, 2014, Leukemia.

Diagnostic Discrepancies in Small-volume Biopsy for the Initial Diagnosis, Recurrence, and Transformation of Follicular Lymphoma

Y. Natkunam, O. Lin, R. Ruiz-Cordero, 2022, The American journal of surgical pathology.

mTORC1 links pathology in experimental models of Still’s disease and macrophage activation syndrome

L. Henderson, Zhengping Huang, P. Nigrovic, 2022, Nature Communications.

Identification of germline variants in adults with hemophagocytic lymphohistiocytosis.

J. Aster, B. Ebert, A. Schram, 2020, Blood advances.

Bone Marrow Reticulin in Patients with Immune Thrombocytopenic Purpura.

B. Bain, G. Mufti, A. Bagg, 2006 .

Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis

S. Rodig, J. Cortes, R. Stone, 2015, Journal of Translational Medicine.

Case records of the Massachusetts General Hospital. Case 36-2010. A 50-year-old woman with pain and loss of hearing in the left ear.

K. Stankovic, A. Juliano, R. Hasserjian, 2010, The New England journal of medicine.

Case records of the Massachusetts General Hospital. Case 11-2007. A 59-year-old man with neck pain, weakness in the arms, and cranial-nerve palsies.

A. Steere, P. Schaefer, D. Greer, 2007, The New England journal of medicine.

Case 11-2007 : A 59-Year-Old Man with Neck Pain , Weakness in the Arms , and Cranial-Nerve Palsies

A. Steere, P. Schaefer, D. Greer, 2007 .

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features

B. Woda, A. Raza, N. Galili, 2006, Leukemia.

Acute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive Mimics: A Guide to a Number of Perplexing Entities.

Sa A. Wang, R. Hasserjian, 2015, American journal of clinical pathology.

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS).

Tae Kon Kim, R. Bejar, O. Abdel-Wahab, 2023, Blood reviews.

Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group

L. Saft, A. Tzankov, F. Fend, 2018, Pathobiology.

Inter-reader variability in follicular lymphoma grading: Conventional and digital reading

Gerard Lozanski, Michael Pennell, Arwa Shana’ah, 2013, Journal of pathology informatics.

Diffuse L arge B - Cell Lymphomas a nd Burkitt Lymphoma

L. Leval, R. Hasserjian, 2009 .

Routine conventional karyotyping of lymphoma staging bone marrow samples does not contribute clinically relevant information

P. D. Dal Cin, J. Abramson, V. Nardi, 2015, American journal of hematology.

Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis

U. Surti, N. Harris, S. Swerdlow, 2011, Haematologica.

Evidence of Long Latency Periods Prior to Development of Mantle Cell Lymphoma

K. Blum, B. Christian, Weiqiang Zhao, 2010 .

Moving toward more molecular classifications of myelodysplastic syndrome and acute myeloid leukemia

D. Arber, R. Hasserjian, A. Orazi, 2022, American journal of hematology.

International Consensus Classification for myeloid neoplasms at‐a‐glance

M. Cazzola, H. Döhner, D. Arber, 2022, American journal of hematology.

Diagnosis of Burkitt Lymphoma and Related High-Grade B-Cell Neoplasms.

A. Sohani, R. Hasserjian, 2010, Surgical pathology clinics.

Controversies in the recent (2016) World Health Organization classification of acute myeloid leukemia.

R. Hasserjian, 2021, Best practice & research. Clinical haematology.

Kikuchi-Fujimoto Lymphadenitis

R. Hasserjian, Anthony W. S. Chi, 2019, Encyclopedia of Pathology.

Kikuchi-Fujimoto lymphadenitis: role of parvovirus B-19, Epstein-Barr virus, human herpesvirus 6, and human herpesvirus 8.

Yi-Wei Tang, C. Mosse, R. Hasserjian, 2013, Human pathology.

Chronic lymphocytic leukemia/small lymphocytic lymphoma: another neoplasm related to the B-cell follicle?

U. Surti, S. Swerdlow, R. Hasserjian, 2015, Leukemia & lymphoma.

Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

A. LaCasce, D. Neuberg, P. Armand, 2011 .

Cancer Therapy : Clinical Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

A. LaCasce, D. Neuberg, P. Armand, 2011 .

Marginal zone B‐cell lymphoma of the infratemporal fossa: A rare case and review

K. Emerick, R. Hasserjian, Megan M. Abbott, 2010, The Laryngoscope.

High Grade Lymphoma Mimicking Advanced Nasopharyngeal Carcinoma

Amanda L. Silver, R. Hasserjian, Ricard Masia, 2009 .

Commentary on the WHO classification of tumors of lymphoid tissues (2008): “Gray zone” lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma

D. de Jong, G. Ott, K. Elenitoba-Johnson, 2009, Journal of hematopathology.

Aleukemic cutaneous myeloid sarcoma

L. Le, S. Kraft, R. Nazarian, 2013, Journal of cutaneous pathology.

Effect of DNMT3A variant allele frequency and double mutation on clinicopathologic features of patients with de novo AML.

O. Weinberg, R. Hasserjian, O. Pozdnyakova, 2021, Blood advances.

Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms (Excluding Acute Leukemias).

E. Morgan, T. Kelley, F. Fend, 2019, American journal of clinical pathology.

Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study

A. Bagg, L. Peterson, T. George, 2017, American journal of clinical pathology.

Bone marrow niches in haematological malignancies

J. Gribben, D. Steensma, I. Ghobrial, 2020, Nature Reviews Cancer.

Molecular testing for JAK2, MPL, and CALR in myeloproliferative neoplasms

D. Xia, R. Hasserjian, 2016, American journal of hematology.

Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms

R. Bejar, C. Hourigan, D. Steensma, 2022, Leukemia.

NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype.

N. Harris, R. Hasserjian, 2007, American journal of clinical pathology.

Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas

S. Pileri, H. Stein, N. Bolli, 2007, Leukemia.

On-chip recapitulation of clinical bone-marrow toxicities and patient-specific pathophysiology

Carlos F. Ng, D. Ingber, Cailin E. Joyce, 2019, Nature Biomedical Engineering.

Human bone marrow disorders recapitulated in vitro using organ chip technology

Carlos F. Ng, D. Ingber, Cailin E. Joyce, 2018, bioRxiv.

Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome.

A. Seegmiller, R. Hasserjian, O. Pozdnyakova, 2019, Blood advances.

Erythroid proliferations in myeloid neoplasms.

Sa A. Wang, R. Hasserjian, 2012, Human pathology.

Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

V. Nardi, R. Hasserjian, 2016, Surgical pathology clinics.

A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma.

N. Harris, A. Rahemtullah, Nancy L Harris, 2006, American journal of clinical pathology.

Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study.

A. Bagg, D. Arber, S. Verstovsek, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Marginal zone B‐cell lymphoma of the head and neck: a rare case and review

K. Emerick, M. E. McLellan, R. Hasserjian, 2010, The Laryngoscope.

Advances in the diagnosis and classification of myelodysplastic syndromes

R. Hasserjian, 2015 .

Cat Scratch Lymphadenitis

Amelia E. Huck, R. Hasserjian, 2019, Encyclopedia of Pathology.

Sinus Histiocytosis

R. Hasserjian, Anthony W. S. Chi, 2019, Encyclopedia of Pathology.

Ring chromosome in myeloid neoplasms is associated with complex karyotype and disease progression.

P. D. Dal Cin, R. Hasserjian, O. Pozdnyakova, 2017, Human pathology.

Follicular Dendritic Cell Sarcoma of Uterine Corpus: Report of 2 Cases.

E. Oliva, R. Hasserjian, Baris Boyraz, 2022, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Commentary on the WHO classification of tumors of lymphoid tissues (2008): aggressive B-cell lymphomas

D. de Jong, G. Ott, K. Elenitoba-Johnson, 2009, Journal of hematopathology.

Tumor microenvironment for follicular lymphoma: structural analysis for outcome prediction

Berkman Sahiner, Metin Nafi Gürcan, W. Chen, 2018, Medical Imaging.

Finding the True Hits in Double-Hit Lymphomas

Robert P. Hasserjian, R. Hasserjian, 2021, The Hematologist.

How I Diagnose Low-Grade Myelodysplastic Syndromes.

R. Hasserjian, A. Siddon, 2020, American journal of clinical pathology.

Characterization of applicants for residency training in pathology: Does diversity exist?

D. Louis, W. S. Black-Schaffer, R. Nazarian, 2019, Annals of diagnostic pathology.

Pediatric myelodysplastic syndrome.

K. Calvo, R. Hasserjian, Stephen J. Babcock, 2023, Seminars in diagnostic pathology.

Assessment of myeloid and monocytic dysplasia by flow cytometry in de novo AML helps define an AML with myelodysplasia-related changes category

O. Weinberg, R. Hasserjian, O. Pozdnyakova, 2016, Journal of Clinical Pathology.

Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group

Philipp W. Raess, G. Pinkus, A. Bagg, 2023, Leukemia & lymphoma.

Twin Girls with Neurocutaneous Symptoms Caused by Mothball Intoxication

A. Zhu, R. Hasserjian, J. Schwartz, 2006 .

Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms.

M. Ewalt, A. Harrington, S. Kroft, 2016, American journal of clinical pathology.

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 2-2005. A 39-year-old woman with headache, stiff neck, and photophobia.

K. Ballen, R. Hasserjian, 2005, The New England journal of medicine.

High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome

A. Iafrate, P. Cin, Zongli Zheng, 2015, Modern Pathology.

Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms.

S. Sadigh, G. Hobbs, R. Hasserjian, 2020, Current opinion in hematology.

FOXP3-stained image analysis for follicular lymphoma: optimal adaptive thresholding with maximal nucleus coverage

Berkman Sahiner, Metin Nafi Gürcan, W. Chen, 2017, Medical Imaging.

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

A. Viale, M. Cazzola, D. Neuberg, 2020, Nature Medicine.

Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia

J. Downing, B. Taylor, J. Aster, 2020, Leukemia.

Massive hepatomegaly and involvement by Janus kinase 2–positive myeloproliferative neoplasm

J. Lennerz, D. Kuter, R. Hasserjian, 2010, Hepatology.

Updates in Classification of Myelodysplastic Syndrome

Mina L. Xu, R. Hasserjian, 2023, Cancer journal.

Combined Targeted Therapy for BRAF-Mutant, Treatment-Related Acute Myeloid Leukemia.

T. Graubert, S. Wander, A. Fathi, 2017, JCO precision oncology.

Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression

J. Scandura, M. Ponzoni, P. Ronchi, 2020, Haematologica.

Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group.

A. Bagg, W. Tam, D. Arber, 2023, JCO precision oncology.

Lymphadenitis

D. B. Chou, R. Hasserjian, 2019, Encyclopedia of Pathology.

Prognostic Significance of Residual Acute Myeloid Leukemia in Bone Marrow Samples Taken Prior to Allogeneic Hematopoietic Cell Transplantation

A. Fathi, Yi-Bin Chen, A. Brunner, 2017, American journal of clinical pathology.

Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes.

G. Garcia-Manero, P. Scheinberg, N. Daver, 2023, Blood.

Castleman disease presenting in the neck: report of a case and review of the literature.

W. Faquin, J. Rocco, Harrison W. Lin, 2013, American journal of otolaryngology.

Genomic Profiling for Clinical Decision Making in Myeloid Neoplasms and Acute Leukemia.

Anna L. Brown, Annette S. Kim, M. Loh, 2022, Blood.

Co-occurrence of Langerhans cell histiocytosis and Rosai–Dorfman disease: possible relationship of two histiocytic disorders in rare cases

P. Banks, T. Barry, R. Jaffe, 2010, Modern Pathology.

Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group.

A. Bagg, W. Tam, D. Arber, 2023, Leukemia research.

Prognostic Impact of Secondary Versus De Novo Ontogeny in Acute Myeloid Leukemia (AML) Is Predominantly Accounted for By the European Leukemianet (ELN) 2022 Risk Classification

E. Estey, C. Hourigan, J. Karp, 2022, Blood.

A distinct immunophenotype identifies a subset of NPM1‐mutated AML with TET2 or IDH1/2 mutations and improved outcome

F. Kuo, A. Seegmiller, R. Hasserjian, 2018, American journal of hematology.

The international consensus classification of eosinophilic disorders and systemic mastocytosis

D. Arber, A. Tzankov, J. Gotlib, 2023, American journal of hematology.

Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements

G. Garcia-Manero, T. Kadia, F. Ravandi, 2023, American journal of hematology.

Guiding the global evolution of cytogenetic testing for hematologic malignancies

P. D. Dal Cin, F. Solé, R. Levine, 2022, Blood.

A directly spliced exon 10-containing CD44 variant promotes the metastasis and homotypic aggregation of aggressive non-Hodgkin's lymphoma.

D. Neuberg, M. Shipp, S. Kharbanda, 1998, Blood.

Pharmacokinetics of an oral VEGF receptor tyrosine kinase inhibitor (PTK787/ZK222584) in patients with myelodysplastic syndrome (MDS): Cancer and Leukemia Group B Study 10105.

K. Owzar, M. Ratain, R. Vij, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

R. Bejar, O. Abdel-Wahab, P. Greenberg, 2022, Blood advances.

Normal and chronic phase CML hematopoietic cells repopulate NOD/SCID bone marrow with different kinetics and cell lineage representation.

J. Goldman, M. Gordon, F. Dazzi, 2000, The hematology journal : the official journal of the European Haematology Association.

Myelodysplastic/ Myeloproliferative Neoplasms-Unclassifiable (MDS/MPN-U) with Isolated Isochromosome 17q Represents a Distinct Clinico-Biologic Subset: A Multi-institutional Collaborative Study from the Bone Marrow Pathology Group

K. Do, P. Cin, A. Bagg, 2021, Modern Pathology.

Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia

Adam Bagg, Zhengming Chen, Wayne Tam, 2017, Modern Pathology.

Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial

T. Manshouri, S. Verstovsek, K. Trunzer, 2023, Haematologica.

Response to “The WHO classification of haematolymphoid tumours” (Editorial)

E. Campo, A. Zelenetz, J. Winter, 2022, Leukemia.

Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach

M. Cazzola, H. Döhner, D. Arber, 2022, American journal of hematology.

Morphologic Characteristics of Myelodysplastic Syndromes

R. Hasserjian, Lisa Yuen, 2023, Clinics in Laboratory Medicine.

Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1

A. Bagg, W. Tam, D. Arber, 2020, Modern Pathology.

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).

Tae Kon Kim, R. Bejar, O. Abdel-Wahab, 2023, Blood reviews.

Pure erythroid leukemia evolving from a therapy‐related myelodysplastic syndrome secondary to treatment for chronic lymphocytic leukemia

A. Fathi, H. Sadrzadeh, R. Hasserjian, 2013, American journal of hematology.

Genetic Background Influences the Growth of CHIP Clones Within the Bone Marrow

R. Hasserjian, 2023, The Hematologist.

Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification

E. Estey, C. Hourigan, J. Karp, 2023, Leukemia.

Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach.

A. Bagg, D. Arber, C. Bueso-Ramos, 2023, American journal of clinical pathology.

Presence but not number of secondary type mutations influences outcome in de novo AML without MDS‐associated or recurring cytogenetic abnormalities

D. Arber, J. Gagan, R. Hasserjian, 2023, EJHaem.

Acute myeloid leukemia in a patient with constitutional 47,XXY karyotype

P. Cin, A. Fathi, A. Brunner, 2015, Leukemia research reports.

Sinus histiocytosis with massive lymphadenopathy. Report of a case associated with elevated EBV antibody titers

R. Reed, R. Hasserjian, G. Newell, 1973, Cancer.

Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures

J. Aster, W. Wong, R. Hasserjian, 2019, PloS one.

Computer‐assisted quantification of CD3+ T cells in follicular lymphoma

Berkman Sahiner, Gerard Lozanski, Weijie Chen, 2017, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Dermatopathic Lymphadenitis

Amelia E. Huck, R. Hasserjian, 2019, Encyclopedia of Pathology.

Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim.

B. Bain, G. Mufti, D. Kuter, 2009 .

Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim.

B. Bain, G. Mufti, D. Kuter, 2009, Blood.

PRM-151 in Myelofibrosis: Durable Efficacy and Safety at 72 Weeks

M. Salama, H. Kantarjian, S. Verstovsek, 2015 .

Case 9-2011: A 37-Year-Old Man with Flushing and Hypotension

M. Castells, R. Hasserjian, A. Cort, 2011 .

Nuclear IHC enumeration: A digital phantom to evaluate the performance of automated algorithms in digital pathology

Berkman Sahiner, Fazly Salleh Abas, John Opfer, 2018, PloS one.

Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement.

R. Siebert, N. Harris, A. Iafrate, 2012, Blood.

Commentary on the WHO classification of tumors of lymphoid tissues (2008): “Gray zone” lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma

D. de Jong, G. Ott, K. Elenitoba-Johnson, 2009, Journal of hematopathology.

Follicular Hyperplasia

D. B. Chou, R. Hasserjian, 2019, Encyclopedia of Pathology.

Commentary on the WHO classification of tumors of lymphoid tissues (2008): aggressive B-cell lymphomas

D. de Jong, G. Ott, K. Elenitoba-Johnson, 2009, Journal of hematopathology.

Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis

U. Surti, N. Harris, S. Swerdlow, 2011, Haematologica.

Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim.

B. Bain, G. Mufti, D. Kuter, 2009, Blood.

STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia.

A. Bagg, M. Routbort, Z. Zuo, 2023, Haematologica.

S828 A RANDOMIZED, DOUBLE BLIND PHASE 2 STUDY OF 3 DIFFERENT DOSES OF PRM-151 IN PATIENTS WITH MYELOFIBROSIS WHO WERE PREVIOUSLY TREATED WITH OR INELIGIBLE FOR RUXOLITINIB

S. Verstovsek, M. Wadleigh, R. Mesa, 2019, HemaSphere.

Effect Of Treatment With The JAK2-Selective Inhibitor Fedratinib (SAR302503) On Bone Marrow Histology In Patients With Myeloproliferative Neoplasms With Myelofibrosis

S. Rodig, J. Cortes, R. Stone, 2013 .

Bone progenitor dysfunction induces myelodysplasia and secondary leukemia

Charles P. Lin, J. Rommens, B. Ebert, 2010, Nature.

Computer vision quantitation of erythrocyte shape abnormalities provides diagnostic, prognostic, and mechanistic insight

Jonathan A Stefely, J. Higgins, H. Al‐Samkari, 2023, Blood advances.

Cutaneous manifestations of myeloid neoplasms exhibit broad and divergent morphologic and immunophenotypic features, but share ancestral clonal mutations with bone marrow.

Scott B. Lovitch, R. Hasserjian, O. Pozdnyakova, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.